Suction-assisted lipectomy for lipodystrophy syndromes attributed to HIV-protease inhibitor use

Plastic and Reconstructive Surgery

Volumn 104, Issue 6, 1999, Pages 1814-1820

  Wolfort, Francis G ^a   Cetrulo Jr , Curtis L ^a   Nevarre, Daniel R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CASE REPORT; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; LIPOSUCTION; PATHOGENESIS; PRIORITY JOURNAL; NOTE; SUCTION; SURGICAL TECHNIQUE;

EID: 0032751963     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006534-199911000-00032     Document Type: Article

References (32)

1. Deeks, S. G., Smith, M., Holodniy, M., and Kahn, J. O. HIV-1 protease inhibitors: A review for clinicians. J.A.M.A. 277: 145, 1997.
2. Flexner, C. HIV-protease inhibitors. N. Engl. J. Med. 338: 1281, 1998.
3. Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., et al. Antiretroviral therapy for HIV infection 1997: Updated recommendations of the International AIDS Society-USA Panel. J.A.M.A. 277: 1962, 1997.
4. British HIV Association Guidelines Co-ordinating Committee. British HIV Association Guidelines for anti-retroviral therapy of HIV seropositive individuals. Lancet 349: 1086, 1997.
5. Centers for Disease Control AIDS statistics Web page (www.cdc.gov/nchstp/hiv aids/pubs/facts.htm).
6. Carr, A., and Cooper, D. A. Images in clinical medicine: Lipodystrophy associated with an HIV-protease inhibitor. N. Engl. J. Med. 339: 1296, 1998.
7. Carr, A., Samaras, K., Chisholm, D. J., and Cooper, D. A. Abnormal fat distribution and use of protease inhibitors. Lancet 351: 1736, 1998.
8. Ho, T. T., Chan, K. C., Wong, K. H., and Lee, S. S. Abnormal fat distribution and use of protease inhibitors. Lancet 351: 1736, 1998.
9. Shaw, A. J., McLean, K. A., and Evans, B. A. Disorders of fat distribution in HIV infection. Int. J. S.T.D. A.I.D.S. 9: 595, 1998.
10. Stricker, R. B., and Goldberg, B. Fat accumulation and HIV-1 protease inhibitors. Lancet 352: 1392, 1998.
11. Stricker, R. B., and Goldberg, B. Weight gain associated with protease inhibitor therapy in HIV-infected patients. Res. Virol. 149: 123, 1998.
12. Silva, M., Skolnick, P. R., Gorbach, S. L., et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. A.I.D.S. 12: 1645, 1998.
13. Lo, J. C., Mulligan, K., Tai, V. W., Algren, H., and Schambelan, M. "Buffalo hump" in men with HIV infection. Lancet 351: 867, 1998.
14. Mishriki, Y. Y. A baffling case of bulging belly: Protease paunch. Postgrad. Med. 104: 45, 1998.
15. Miller, K. D., Jones, E., Yanovski, J. A., Shankar, R., Feuerstein, I., and Falloon, J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 351: 871, 1998.
16. Dong, K., and Flynn, M. Change in Body Habitus of Women after Initiation of Protease Inhibitor Therapy. Abstract 12373 from the 12th World AIDS Conference, Geneva, Switzerland, 1998.
17. Schurmann, D., Bergmann, F., Ehrenstein, T., and Padberg, J. Gynecomastia in a male patient during protease inhibitor treatment for acute HIV disease. A.I.D.S. 12: 2232, 1998.
18. Massip, P., Marchou, B., Bonnet, E., Cuzin, L., and Montastruc, J. L. Lipodystrophia with protease inhibitors in HIV patients. Therapie 52: 615, 1997.
19. Viraben, R., and Aquilina, C. Indinavir-associated lipodystrophy. A.I.D.S. 12: F37, 1998.
20. Perrot, H. Localized lipo-atrophies. Ann. Dermatol. Venereol. 115: 523, 1988.
21. Carr, A., Samaras, K., Burton, S., et. al. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors. A.I.D.S. 12: F51, 1998.
22. Carr, A., Samaras, K., Chisholm, D. J., and Cooper, D. A. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 351: 1881, 1998.
23. Walli, R. Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. A.I.D.S. 12: 167, 1998.
24. Stone, V. E., and Hirschhorn, L. R. Discontinuation of protease inhibitor therapy: Reasons and risk factors. Abstract 12443 from the 12th World AIDS Conference, Geneva, Switzerland, 1998.
25. Hepatitis Information Network Web page (www.hepnet-.com/hepc/future.html).
26. Buss, N., and Duff, F. Protease inhibitors in HIV infection: Lipodystrophy may be a consequence of prolonged survival. Br. Med. J. 318: 122, 1999.
27. Kotler, D. P., and Rosenbaum, K. B. Alterations in body fat distribution in HIV infected men and women. Abstract 336/32173 from the 12th World AIDS Conference, Geneva, Switzerland, 1998.
28. Narins, R. S. Liposuction surgery for a buffalo hump caused by Cushing's disease. J. Am. Acad. Dermatol. 21: 307, 1989.
29. Coleman, W. P., III. Noncosmetic applications of liposuction. J. Dermatol. Surg. Oncol. 14: 1085, 1988.
30. Goldwyn, R. M. AIDS, aesthetic surgery, and the plastic surgeon. Plast. Reconstr. Surg. 90: 1061, 1992.
31. Friedland, B. The Americans with Disabilities Act: Should it compel cosmetic treatment for HIV-positive individuals? Plast. Reconstr. Surg. 100: 1061, 1997.
32. Glatt, B. S., Sarwer, D. B., O'Hara, D. E., Hamori, C., Bucky, L. P., and LaRossa, D. A retrospective study of changes in physical symptoms and body image after reduction mammaplasty. Plast. Reconstr. Surg. 103: 76, 1999.